A study of treatment choices in men with erectile dysfunction and reduced androgen levels.
A large cohort of men presenting with erectile dysfunction were offered concurrent measurement of serum total testosterone. Just over one sixth (17.7%) of the initial screening values of patients suggested the possibility of hypogonadism, however, when more rigorous estimation of serum testosterone and associated parameters and the presence of clinical symptoms were applied, 3% of the population had hypergonadotropic hypogonadism. Only 10 of 44 (22.7%) eligible men agreed to a trial of testosterone therapy, however, two thirds of this eligible group also required another erectogenic agent to resolve the erectile dysfunction.
Wylie
Kevan
K
Porterbrook Clinic, Sheffield, United Kingdom. k.r.wylie@sheffield.ac.uk
Davies-South
Deborah
D
D000328:Adult; D000368:Aged; D000728:Androgens / Q000172:deficiency; D015331:Cohort Studies; D007172:Erectile Dysfunction / Q000097:blood / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007006:Hypogonadism / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013739:Testosterone / Q000008:administration & dosage* / Q000172:deficiency*; D013997:Time Factors
D000728:Androgens; D013739:Testosterone